S100A1 and glaucoma: Since S100A1 can be secreted in the extracellular space, where high amplitude Zn2+ fluctuations are observed, we propose that it can contribute to pathogenesis of Zn2+-dependent neurodegenerative diseases such as AD and glaucoma [50,51].